Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November

Moderna (NASDAQ:MRNA) started a phase 1 clinical trial for its coronavirus vaccine mRNA-1273 this week. Earlier this month, Inovio Pharmaceuticals (NASDAQ:INO) said it's finishing up preclinical testing of its INO-4800 vaccine and plans to start a clinical trial next month.

Big old Johnson & Johnson (NYSE:JNJ)? The healthcare conglomerate doesn't even have a candidate ye